» Articles » PMID: 38850279

Biodegradable MXene Quantum Dots with High Near-Infrared Photothermal Performance for Cancer Treatment

Overview
Date 2024 Jun 8
PMID 38850279
Authors
Affiliations
Soon will be listed here.
Abstract

Photothermal therapy (PTT) offers significant potential in cancer treatment due to its short, simple, and less harmful nature. However, obtaining a photothermal agent (PTA) with good photothermal performance and biocompatibility remains a challenge. MXenes, which are PTAs, have shown promising results in cancer treatment. This study presents the preparation of TiC MXene quantum dots (MXene QDs) using a simple hydrothermal and ultrasonic method and their use as a PTA for cancer treatment. Compared to conventional MXene QDs synthesized using only the hydrothermal method, the ultrasonic process increased the degree of oxidation on the surface of the MXene QDs. This resulted in the presence of more hydrophilic groups such as hydroxyl groups on the MXene QD surfaces, leading to excellent dispersion in the aqueous system and biocompatibility of the prepared MXene QDs without the need for surface modification. The MXene QDs showed great photothermal performance with a photothermal conversion efficiency of 62.5%, resulting in the highest photothermal conversion efficiency among similar materials reported thus far. Both and experiments have proved the potent tumor inhibitory effect of the MXene QD-mediated PTT, with minimal harm to mice. Therefore, these MXene QDs hold a significant promise for clinical applications.

Citing Articles

Two-Dimensional MXenes: Innovative Materials for Efficient Thermal Management and Safety Solutions.

Hu X, Fan Q, Wang S, Chen Y, Wang D, Chen K Research (Wash D C). 2024; 7:0542.

PMID: 39703779 PMC: 11658421. DOI: 10.34133/research.0542.


Biomimetic CuCoO nanosheets reinforced with self-assembling peptide nanofibers for tumor photothermal therapy.

Xu M, Xu Y, Du C, Gu G, Wei G RSC Adv. 2024; 14(53):39163-39172.

PMID: 39664248 PMC: 11632949. DOI: 10.1039/d4ra07435a.